Cardiovascular Systems

About:

Cardiovascular Systems develops and markets medical devices for the treatment of cardiovascular disease.

Website: http://www.csi360.com

Twitter/X: csi360

Top Investors: Silicon Valley Bank, Partners for Growth, Maverick Ventures, Easton Capital, Mitsui Global Investment

Description:

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Their primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications. Cardiovascular Systems develop solutions for the treatment of peripheral and coronary artery disease, to help physicians conquer calcium, one of the largest challenges when treating PAD and CAD.

Total Funding Amount:

$98M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Saint Paul, Minnesota, United States

Founded Date:

1989-01-01

Contact Email:

generalinquiries(AT)csi360.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2013-03-12

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai